These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma. Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964 [TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth. Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853 [TBL] [Abstract][Full Text] [Related]
6. GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma. Natsumeda M; Miyahara H; Yoshimura J; Nakata S; Nozawa T; Ito J; Kanemaru Y; Watanabe J; Tsukamoto Y; Okada M; Oishi M; Hirato J; Wataya T; Ahsan S; Tateishi K; Yamamoto T; Rodriguez FJ; Takahashi H; Hovestadt V; Suva ML; Taylor MD; Eberhart CG; Fujii Y; Kakita A J Neuropathol Exp Neurol; 2021 Jan; 80(2):129-136. PubMed ID: 33249504 [TBL] [Abstract][Full Text] [Related]
7. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Al-Halabi H; Nantel A; Klekner A; Guiot MC; Albrecht S; Hauser P; Garami M; Bognar L; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N Acta Neuropathol; 2011 Feb; 121(2):229-39. PubMed ID: 21107850 [TBL] [Abstract][Full Text] [Related]
8. Simplified Molecular Subtyping of Medulloblastoma for Reduced Cost and Improved Turnaround Time. Shuangshoti S; Tadadontip P; Techavichit P; Thorner PS; Shuangshoti S; Teerapakpinyo C Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):538-543. PubMed ID: 31343993 [TBL] [Abstract][Full Text] [Related]
9. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation. Iorgulescu JB; Van Ziffle J; Stevers M; Grenert JP; Bastian BC; Chavez L; Stichel D; Buchhalter I; Samuel D; Nicolaides T; Banerjee A; Mueller S; Gupta N; Tihan T; Bollen AW; Northcott PA; Kool M; Pfister S; Korshunov A; Perry A; Solomon DA Acta Neuropathol; 2018 Apr; 135(4):635-638. PubMed ID: 29435664 [No Abstract] [Full Text] [Related]
10. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma. Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241 [TBL] [Abstract][Full Text] [Related]
11. Hedgehog pathway permissive conditions allow generation of immortal cell lines from granule cells derived from cancerous and non-cancerous cerebellum. Heil C Open Biol; 2019 Jan; 9(1):180145. PubMed ID: 30958113 [TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation. Cambruzzi E Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169 [TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma molecular dissection: the way toward targeted therapy. Remke M; Ramaswamy V; Taylor MD Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539 [TBL] [Abstract][Full Text] [Related]
15. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018 [TBL] [Abstract][Full Text] [Related]
16. Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon. Gulacsi AA; Anderson SA Nat Neurosci; 2008 Dec; 11(12):1383-91. PubMed ID: 18997789 [TBL] [Abstract][Full Text] [Related]
17. Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. Tang M; Villaescusa JC; Luo SX; Guitarte C; Lei S; Miyamoto Y; Taketo MM; Arenas E; Huang EJ J Neurosci; 2010 Jul; 30(27):9280-91. PubMed ID: 20610763 [TBL] [Abstract][Full Text] [Related]
18. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma. Doucette TA; Yang Y; Pedone C; Kim JY; Dubuc A; Northcott PD; Taylor MD; Fults DW; Rao G Neurosurgery; 2012 Apr; 70(4):1003-10; discussion 1010. PubMed ID: 22037313 [TBL] [Abstract][Full Text] [Related]
19. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression. Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842 [TBL] [Abstract][Full Text] [Related]
20. Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours. Łastowska M; Jurkiewicz E; Trubicka J; Daszkiewicz P; Drogosiewicz M; Malczyk K; Grajkowska W; Matyja E; Cukrowska B; Pronicki M; Perek-Polnik M; Perek D; Dembowska-Bagińska B J Neurooncol; 2015 May; 123(1):65-73. PubMed ID: 25862008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]